B-NHL BFM 04 - B-NHL BFM 04
- Conditions
- B-cell lymphoma or B-ALL in children up to 18 years of age
- Registration Number
- EUCTR2005-002345-39-SE
- Lead Sponsor
- OPHO NHL-group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 180
All patients with a mature B-cell non-Hodgkin lymphoma or B-ALL in Sweden fulfilling the following criteria:
Verified diagnosis
Written concent from patient/parent
Under 19 years of age
Start of treatment within the study period
Treatment at a centre participating in the study
No inclusion in other study protocols
Pregnancy excluded in female patients
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Previous malignancy
Severe immunodeficiency
HIV/AIDS
Prevoius organ transplantation
Concomittant disease interferring with treatment according to the protocol
Treatment with cytostatic drugs, corticosteroids or irradtiation during the two weeks preceeding start of treament according to the study protocol
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method